Table 1: Baseline characteristics of the study population.

 OverallLOFNo LOF value
 

Age67.067.066.00.7
Male gender36 (64.3)29 (65.9)7 (58.3)0.7
Smoking10 (17.9)7 (15.9)3 (25.0)0.4
Hypertension33 (58.9)25 (56.8)8 (66.7)0.7
Diabetes mellitus15 (26.8)11 (25.0)4 (33.3)0.7
Dyslipidemia12 (21.4)9 (20.5)3 (25.0)0.7
Prior MI3 (5.4)1 (2.3)2 (16.7)0.1
Prior PCI11 (19.6)7 (15.9)4 (33.3)0.2
BMI24.826.124.30.2
Statin15 (26.8)13 (29.5)2 (16.7)0.5
-blocker9 (16.1)5 (11.4)4 (33.3)0.09
ACE inhibitor4 (7.1)3 (6.8)1 (8.3)1
CCBs11 (19.6)8 (18.2)3 (25.0)0.7
PPIs2 (3.6)1 (2.3)1 (8.3)0.4
Platelet count215.5221.0215.51
C-reactive protein0.10.10.10.2

The denotations are LOF: loss-of-function; MI: myocardial infarction; PCI: percutaneous coronary intervention; BMI: body mass index; ACE: angiotensin converting enzyme inhibitor; CCB: calcium channel blocker; and PPI: proton pump inhibitor.